Erythromyeloid-derived TREM2: A major determinant of Alzheimer's disease pathology in down syndrome

Autor: Raha-Chowdhury, R., Henderson, J.W., Raha, A.A., Stott, S.R.W., Vuono, R., Foscarin, S., Wilson, L., Annus, T., Fincham, R., Allinson, K., Devalia, V., Friedland, R.P., Holland, A., Zaman, S.H.

Background: Down syndrome (DS; trisomy 21) individuals have a spectrum of hematopoietic and neuronal dysfunctions and by the time they reach the age of 40 years, almost all develop Alzheimer's disease (AD) neuropathology which includes senile plaques

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::3d3bea6da515f392ac90c12d7d2af0f9
https://kar.kent.ac.uk/79835/1/jad_2018_61-3_jad-61-3-jad170814_jad-61-jad170814.pdf

Common Non-Rheumatic Medical Conditions Mimicking Fibromyalgia: A Simple Framework for Differential Diagnosis.

Autor: D'Amuri, Andrea¹ (AUTHOR) andrea.damuri@asst-mantova.it, Greco, Salvatore² (AUTHOR) salvatore.greco@unife.it, Pagani, Mauro¹ (AUTHOR) mauro.pagani@asst-mantova.it, Presciuttini, Barbara¹ (AUTHOR) barbara.presciuttini@asst-mantova.it, Ciaffi, Jacopo^3,4 (AUTHOR) francesco.ursini2@unibo.it, Ursini, Francesco^3,4 (AUTHOR)

Publikováno v: Diagnostics (2075-4418). Aug2024, Vol. 14 Issue 16, p1758. 24p.

Aplasia medular carencial por anemia perniciosa hereditaria.

Autor: Vargas Nieto, Lina Patricia¹, Estrada Maya, Juan P.², Vargas Osorno, Manuela³ manuelavargas.med@gmail.com, Medina Rincón, Germán J.³

Publikováno v: Medicina Interna de Mexico. jul2024, Vol. 40 Issue 6, p388-394. 7p.

Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.

Autor: Raha-Chowdhury R; Department of Clinical Neuroscience, John Van Geest Centre for Brain Repair, Cambridge, UK.; Department of Psychiatry, Cambridge Intellectual and Developmental Disabilities Research Group, University of Cambridge, Cambridge, UK., Henderson JW; Department of Clinical Neuroscience, John Van Geest Centre for Brain Repair, Cambridge, UK., Raha AA; Department of Clinical Neuroscience, John Van Geest Centre for Brain Repair, Cambridge, UK., Stott SRW; Department of Clinical Neuroscience, John Van Geest Centre for Brain Repair, Cambridge, UK., Vuono R; Department of Clinical Neuroscience, John Van Geest Centre for Brain Repair, Cambridge, UK., Foscarin S; Department of Clinical Neuroscience, John Van Geest Centre for Brain Repair, Cambridge, UK., Wilson L; Department of Psychiatry, Cambridge Intellectual and Developmental Disabilities Research Group, University of Cambridge, Cambridge, UK., Annus T; Department of Psychiatry, Cambridge Intellectual and Developmental Disabilities Research Group, University of Cambridge, Cambridge, UK., Fincham R; Clinical Pathology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Allinson K; Clinical Pathology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Devalia V; Department of Haematology, Luton and Dunstable Hospital NHS Foundation Trust, Luton, UK., Friedland RP; University of Louisville School of Medicine, Louisville, KY, USA., Holland A; Department of Psychiatry, Cambridge Intellectual and Developmental Disabilities Research Group, University of Cambridge, Cambridge, UK., Zaman SH; Department of Psychiatry, Cambridge Intellectual and Developmental Disabilities Research Group, University of Cambridge, Cambridge, UK.

Publikováno v: Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2018; Vol. 61 (3), pp. 1143-1162.

The importance of active B12 (holotranscobalamin) measurement in the diagnosis of vitamin B12 deficiency in type 2 DM patients using metformin.

Autor: Yıldız, Tugce¹ tugceyildiz81@gmail.com, Yıldız, Sevval², Tunc, Muhammed³, Pasin, Ozge⁴, Yıldız, Caner¹, Cakırca, Mustafa³, Karatoprak, Cumali³, Ozer, Omer Faruk¹

Publikováno v: International Journal of Diabetes in Developing Countries. Mar2024, Vol. 44 Issue 1, p106-113. 8p.